Source:http://linkedlifedata.com/resource/pubmed/id/15546343
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2004-11-19
|
pubmed:abstractText |
An altered human leukocyte antigen (HLA) class I expression constitutes an important tumor-escape mechanism counteracting T-cell mediated immune responses. We utilized the technique of microsatellite analysis to characterize the loss of heterozygosity (LOH) in the HLA class I region in 24 samples of patients with human ductal pancreatic carcinoma. The expression of HLA class I and the infiltration by T cells were studied in parallel by standard immunohistochemistry. The present study demonstrates LOH in the HLA class I region in five patients with pancreatic carcinoma. Immunohistochemical analysis showed that pancreatic carcinomas were frequently characterized by a total or partial loss of expression in HLA class I antigen. The positive or negative LOH status corresponded with the expression analysis in eight cases. Reduction of HLA class I expression without LOH was found in 14 cases. Lymphocyte infiltration with CD3+, CD4+, and CD8+ T cells did not show significant differences between LOH-positive and LOH-negative tumors. In conclusion, LOH does not seem to be the only factor for the reduced expression of HLA class I antigen as well as for the T-cell infiltration in this type of tumor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0001-2815
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
696-702
|
pubmed:meshHeading |
pubmed-meshheading:15546343-Antigens, CD3,
pubmed-meshheading:15546343-Antigens, CD4,
pubmed-meshheading:15546343-Antigens, CD8,
pubmed-meshheading:15546343-Carcinoma, Pancreatic Ductal,
pubmed-meshheading:15546343-Chromosomes, Human, Pair 6,
pubmed-meshheading:15546343-Histocompatibility Antigens Class I,
pubmed-meshheading:15546343-Humans,
pubmed-meshheading:15546343-Immunoenzyme Techniques,
pubmed-meshheading:15546343-Loss of Heterozygosity,
pubmed-meshheading:15546343-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:15546343-Microsatellite Repeats,
pubmed-meshheading:15546343-Pancreatic Neoplasms,
pubmed-meshheading:15546343-T-Lymphocytes
|
pubmed:year |
2004
|
pubmed:articleTitle |
Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
|
pubmed:affiliation |
Department of Surgery, University of Heidelberg, Heidelberg, Germany.
|
pubmed:publicationType |
Journal Article
|